CYBERKNIFE TARGETING THE PTERYGOPALATINE GANGLION FOR THE TREATMENT OF CHRONIC CLUSTER HEADACHES

Shivanand P. Lad, John D. Lipani, Iris C. Gibbs, Steven D. Chang, John R. Adler, Jaimie M. HendersonNeurosurgery 2007 · DOI

Abstract

Results of CyberKnife targeting of the pterygopalatine ganglion in a patient with medically intractable CHs have revealed a significant decrease in the severity and frequency of headaches after a 12-month follow-up period. In addition, the patient has been able to reduce his medication intake, allowing for a significant decrease in medication-related side effects. Longer follow-up periods and additional studies are required to determine the long-term efficacy and late side effects of this treatment strategy.
BibTeX
@inproceedings{lad2007cyberknife,
  author = {Shivanand P. Lad and John D. Lipani and Iris C. Gibbs and Steven D. Chang and John R. Adler and Jaimie M. Henderson},
  title = {{CYBERKNIFE TARGETING THE PTERYGOPALATINE GANGLION FOR THE TREATMENT OF CHRONIC CLUSTER HEADACHES}},
  booktitle = {Neurosurgery},
  year = {2007},
  doi = {10.1227/01.neu.0000255348.33582.de},
}

Loading related content...

Figure